Angiotensin-converting enzyme inhibitors and bacterial pneumonia in patients with Parkinson disease

Han Cheng Wang, Che Chen Lin, Chi Ieong Lau, Anna Chang, Chia Hung Kao

研究成果: 雜誌貢獻文章

5 引文 斯高帕斯(Scopus)

摘要

Background: To evaluate the association of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with pneumonia development in patients with Parkinson's disease (PD). Methods: The study cohort consisted of patients aged 50 years or older who were initially diagnosed with PD and had hypertension. We assessed the patients' exposure statuses and accumulated doses of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers. We then evaluated the risk of pneumonia development in the patients who were exposed to these drugs and those who were not. Results: We examined 2,310 patients. During the observation period, 608 patients developed pneumonia. Angiotensin-converting enzyme inhibitors were associated with a lower risk of pneumonia. This association was dose-dependent. Conclusion: Angiotensin-converting enzyme inhibitor use was associated with a dose-dependent reduction in the risk of pneumonia in patients with PD and hypertension.
原文英語
頁(從 - 到)593-596
頁數4
期刊Movement Disorders
30
發行號4
DOIs
出版狀態已發佈 - 四月 1 2015

    指紋

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

引用此